
Euan Rellie
Managing Partner, Chairman of Consumer & Retail
New York
Euan Rellie is Co-Founder and Managing Partner of BDA, based in New York. He is also President of BDA Advisors Inc, the firm’s SEC/FINRA registered broker-dealer.
Since founding BDA in 1996, he has lived in New York, London and Singapore. He has worked in China, Hong Kong, India, Japan, Korea, Singapore, Vietnam, and across the Middle East. 1990-1996, he worked for Schroders, the UK investment bank now part of Citigroup, in New York, London and Singapore. He was Head of SE Asia Execution for Schroders Asia-Pacific Regional Advisory Group. His clients have included Ardian, Bain Capital, CITIC Capital, Dainippon Ink & Chemical, DuPont, Ecolab, Flex, Hanjin, Happy Socks, ICICI, Intel, Investcorp, Kraft Foods, Lavazza, Life Technologies, Lubrizol, Materion, Nalco, On Semi, One Equity Partners, OpenGate Capital, Pfizer, Philip Morris, Platinum Equity, Sara Lee, Shimano, Sigma-Aldrich, Tenneco, Terex, ThomsonReuters, Wockhardt and Yucaipa.
He is the recipient of the 2023 M&A Advisor Leadership Award, was named Dealmaker of the Year in 2016 and 2012 (by The M&A Advisor), 2014 North American Investment Banker of the Year, and one of the Top 50 Global M&A Dealmakers (by The Global M&A Network). He was educated at Eton and Trinity College, Cambridge.
Recent transactions

raised Series C capital from

and other investors
2025

acquired 75% stake in


2024

a portfolio company of

has been acquired by

2024

received investment from


2023

raised growth capital from

Beall Investment Partners and

2023

acquired


2023

a portfolio company of

has been sold to

2023

divested India business and formed partnership with

backed by

2022

divested Niigata fab to


Sangyo Sosei and Fukuoka Capital
2022

acquired by

a portfolio company of

2022

divested

to

2022

has been acquired by


2022

raised US$50m in Series B capital and formed a strategic partnership with

2022

has been acquired by


2022

has been acquired by


2021

divested China phenolic resins plant to


2021

has been acquired by

and

2020

divested Escientia Life Sciences to Deccan Fine Chemicals


2020

a portfolio company of

has been acquired by

2020

divested to

a portfolio company of

2020












